WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc., a second generation RNA interference company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™, today announced presentations at two upcoming conferences: the RNAi World Congress 2009, May 14-15, in Boston; and TIDES® 2009, the Oligonucleotide and Peptide Technology and Product Development Conference, May 17-20, in Las Vegas.
